Lantern Pharma Inc [LTRN] stock prices are up 24.36% to $8.27 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The LTRN shares have gain 99.28% over the last week, with a monthly amount glided 95.97%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 5, March 2024, Lantern To Participate in H.C Wainwright & Co.’s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference. In a post published today on Yahoo Finance, Lantern Pharma will present virtually on Thursday, March 7th at 2 pm Eastern.
From an analyst’s perspective:
Lantern Pharma Inc [NASDAQ: LTRN] stock has seen the most recent analyst activity on October 07, 2021, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $32.
The stock price of Lantern Pharma Inc [LTRN] has been fluctuating between $2.38 and $6.67 over the past year. Lantern Pharma Inc [NASDAQ: LTRN] shares were valued at $8.27 at the most recent close of the market.
Analyzing the LTRN fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.28 and Total Capital is -0.37. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.90 points at the first support level, and at 5.53 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.61, and for the 2nd resistance point, it is at 10.96.
Lantern Pharma Inc [LTRN] reported earnings per share of -$0.29 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.45/share, meaning a difference of $0.16 and a surprise factor of 35.60%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.44 per share as compared to estimates of -$0.43 per share, a difference of -$0.01 representing a surprise of -2.30%.
Ratios To Look Out For
It’s worth pointing out that Lantern Pharma Inc [NASDAQ:LTRN]’s Current Ratio is 21.05. Further, the Quick Ratio stands at 21.05, while the Cash Ratio is 11.35.
Transactions by insiders
Recent insider trading involved Kreis Leslie W., 10% Owner, that happened on Feb 29 ’24 when 19703.0 shares were sold. 10% Owner, Fletcher Aaron G.L. completed a deal on Feb 29 ’24 to sell 19703.0 shares. Meanwhile, 10% Owner Fletcher Aaron G.L. sold 74297.0 shares on Feb 28 ’24.
